PPK Group Limited Overview
PPK Group is a small-cap Brisbane-based holding company that has reinvented itself several times: from a plastics packaging business (Plaspak, 1979), to a mining equipment manufacturer, to a university-sourced technology incubator built around boron nitride nanomaterials licensed from Deakin University. It is now a capital allocator that holds one controlled operating business — PowerPlus Energy (75.4%), an Australian manufacturer of lithium iron phosphate (LFP) batteries and battery energy storage systems — and two equity-accounted associates: ASX-listed Li-S Energy (39.11%), which develops lithium-sulfur cells for drones and defence, and the merged White Graphene/BNNT nanomaterials business (39.36%). In June 2026, PPK sold its 39.85% stake in Craig International Ballistics for A$27.2m in cash plus up to about A$6.0m in earn-out. This leaves the group with roughly A$27.7m of cash, a A$2.5m on-market buy-back, and a stated plan to buy outright one high-quality Australian operating business as its future cornerstone.
Company's own description (FY26 Annual Report, paraphrased)
The FY26 Directors' Report describes PPK's principal continuing activity as investing capital and expertise in high-potential opportunities. Its current focus is energy storage, safety-related products and nanomaterials. The stated aim is to strengthen each investment and exit it when appropriate. The portfolio during FY26 comprised:
-
energy storage assets: Li-S Energy Limited and PowerPlus Energy Pty Ltd;
-
ballistic protection via Craig International Ballistics Pty Ltd (sold 29 June 2026); and
-
nanomaterials: BNNT Technology Pty Ltd and White Graphene Limited (merged July 2025, deconsolidated November 2025).
PPK also provides finance, IT, legal, cyber security, payroll, capital-raising and transactional shared services to portfolio companies. Those companies pay fees that partially recover PPK's corporate costs. Management fees received fell from A$1.613m in FY25 to A$0.945m in FY26 (FY26 Annual Report).
The FY26 Chair's Report sets out a new phase. The Board wants to become the long-term owner of an outstanding operating business, acquired outright, rather than a serial acquirer or a speculative investor. It says it will be patient and selective, may look beyond energy storage, and is optimistic of concluding a transaction during FY27.
Independent characterisation
Economically, PPK today is a listed holding company with five layers of value:
-
a cash balance of A$27.7m (consolidated; A$25.7m held directly by PPK at 30 June 2026);
-
a controlled, near-breakeven manufacturing subsidiary (PPE, FY26 revenue A$27.8m, EBITDA A$1.3m);
-
a 39.11% stake in a listed pre-revenue battery developer (LIS, about 251 million shares);
-
a 39.36% stake in an unlisted pre-revenue nanomaterials business (WGL); and
-
contingent receivables: A$0.5m deferred plus up to about A$6.0m CIB earn-out, and an uncapped AMAG earn-out.
Corporate overhead of A$3.6m underlying in FY26 is the main recurring cash drain at the parent level.
Revenue model and mix
| Revenue stream | Model | FY26 relevance |
|---|---|---|
| Battery and BESS product sales (PPE) | Product sales through distributors and installers; volume rebates and rights of return create variable consideration (FY24 Annual Report Note 2.8) | ~100% of consolidated revenue (A$28.709m group vs A$27.764m PPE sales) |
| Shared-services/management fees | Fee-for-service from associates and subsidiaries (eliminated on consolidation for subsidiaries) | A$0.945m received from associates in FY26 |
| Equity-accounted income | Share of associates' profit/loss (CIB, LIS, WGL) | A$0.211m net share of profit in FY26 |
| Dividends/distributions | Cash dividends from associates (CIB) | A$2.397m from CIB (July 2025) |
| Realisations | Gains on disposal/deconsolidation | A$18.308m CIB gain; A$6.937m WGL deconsolidation gain |
| Licensing / subscription | None disclosed | — |
Product vs service mix: consolidated revenue is almost entirely product revenue from PPE. Service revenue is immaterial and largely intra-group.
Value chain position
PPE is a mid-stream assembler and integrator. It sources LFP cells (the Whispr-7 uses CATL cells per the FY25 Annual Report), designs modules, and assembles and tests them in Melbourne. It then integrates complete BESS solutions and sells through an installer and distributor network. LIS sits upstream, as a cell-chemistry and lithium-metal-foil developer. WGL/BNNT is further upstream again, producing advanced additive materials.
Customer types and end-markets
| Business | Customer types | End-markets |
|---|---|---|
| PPE | Electrical installers, distributors, C&I end users, farms, utilities, telcos, eco-tourism, mine sites, residential households (since FY25 via Cheaper Home Batteries Program) | Off-grid, fringe-of-grid and on-grid stationary storage in Australia; residential, agriculture, utilities, tourism, telecommunications, commercial (FY26 Annual Report) |
| LIS (associate) | Drone and aerospace OEMs, defence agencies (US Army DEVCOM C5ISR Center delivery Aug 2026), maritime (MSubs), V-TOL Aerospace, Praetorian Aeronautics | Drones, defence, electric aviation; lithium foil for battery makers |
| WGL/BNNT (associate) | Coatings, lubricants, composites, metal/polymer developers; luxury watchmaker evaluation (FY25); international distributors (e.g. Filgen) | Advanced materials R&D |
| CIB (divested Jun-2026) | Australian Defence Force, police and law enforcement, naval shipbuilding (Hunter Class Frigate transparent armour) | Personal and platform ballistic protection |
Strategy
Stated strategy (FY26 Annual Report themes, paraphrased)
-
Disciplined capital allocation is the Board's foremost responsibility; every decision is tested against long-term value creation.
-
Acquire a cornerstone operating business: a high-quality, Australian-based business that PPK can acquire outright, with capable management and attractive long-term economics. Energy storage is a natural focus, but opportunities beyond it are being considered. The Board wants to be patient and selective, is not seeking to be a serial acquirer, and hopes to conclude a deal in FY27.
-
Return a portion of realised value: an on-market buy-back of up to A$2.5m, about 10% of net CIB proceeds, chosen in preference to a final or special dividend because the shares trade at a material discount to underlying value.
-
Support existing portfolio companies: retained cash gives flexibility to fund PPE scale-up and to support LIS and WGL.
-
Simplify the group: the deconsolidations of LIS (October 2024) and WGL (November 2025) are explicitly framed as improving the clarity of the financial statements and reducing related-party conflicts.
The earlier (FY24) stated mandate was to build a portfolio of growth-stage companies with sovereign Australian manufacturing capability, and to be opportunistic in Australian battery supply-chain consolidation. The FY26 pivot is a material strategic shift: from a multi-asset incubator toward a holding company anchored by one wholly owned operating business.
Initiatives in the last 24 months
| Initiative | Date | Description | Targets / status |
|---|---|---|---|
| LIS deconsolidation and in-specie dividend | Oct 2024 | 5.71c fully franked in-specie distribution of LIS shares | Completed |
| AMAG exit | Oct 2024 | Sale to Transoft | Completed; earn-out pending |
| Board renewal | Jul–Dec 2024 | New Chair; Francis appointed | Completed |
| PPE product roadmap (Eco4847P, Whispr-7, LiNET4835, LiFe4851, Escape 215) | FY25–FY26 | Entry into the residential market via the Cheaper Home Batteries Program | Products launched |
| PPE convertible note facility | Aug 2024 | A$2m facility (PPK A$1m; Molloy entities A$1m) at 10% | A$1.6m drawn at 30 June 2025 |
| Nanomaterials merger | Jul 2025 | WGL and BNNT combined | Completed |
| WGL deconsolidation | Nov 2025 | 22.5m WGL shares sold to a third party | Completed |
| PPE stake increase to 75.4% | Feb 2026 | Settlement of matters with a PPE founder-linked entity | Completed |
| PPE ARENA manufacturing project | Apr 2026 | A$6.7m project, A$2.3m grant; up to 150 MWh per year | Supplier selection under way |
| CIB divestment | Apr–Jun 2026 | Sale to Mehler; A$27.2m cash | Completed |
| On-market buy-back | Aug 2026 | Up to A$2.5m over FY27 | Commenced 31 August 2026 |
| Cornerstone acquisition search | FY27 | Search for an outright acquisition | In progress; update promised at the 24 November 2026 AGM |
| Cyber program | FY25–FY26 | Security operations centre (SOC) monitoring, Essential Eight alignment, data loss prevention (DLP) and user behaviour analytics (UEBA), phishing training | Ongoing |
| Cost program | FY25 | Salary freeze for CEO and CFO in FY25; PPE operational cost cuts | Corporate underlying cost fell from A$6.5m (FY24) to A$3.6m (FY26) |
Medium-term financial targets and guidance
PPK provides no quantitative revenue, earnings or margin guidance. The only quantified forward markers are:
-
the buy-back of up to A$2.5m over FY27;
-
the CIB earn-out of up to about A$6.0m, determined in H1 FY28;
-
PPE's ARENA project target of 150 MWh per year of capacity over about two years; and
-
LIS's Phase 4 feasibility pathway toward up to 1 GWh per year.
Products & Services
Energy Storage — PowerPlus Energy (controlled, 75.4%)
| Product | Description / capabilities (as disclosed) | Target customer | Launch / status | Pricing model |
|---|---|---|---|---|
| LiFe4838P | Rack-mounted modular LFP battery; Clean Energy Council (CEC) certified, opening wider market access | Installers, C&I, off-grid | CEC approval noted in FY23 Annual Report | Not disclosed (distributor/installer pricing) |
| Eco4847P | Rack-mounted LFP battery in the same compact 2RU format, with 17.5% more capacity than its predecessor; CEC accredited late FY25 and eligible for the Cheaper Home Batteries Program | Residential and C&I | Released FY25 | — |
| LiFe4851 | Rack-mounted battery (new/refreshed offering) | C&I, residential | FY26 | — |
| LiNET4835 | Rack-mounted variant co-developed with RFI Technology Solutions to replace ageing lead-acid back-up power | Utilities, telecommunications | FY25 | — |
| Whispr-7 (Whispr residential system) | All-in-one residential system using CATL cells and a silent-running inverter; CEC approved; developed with Redx Technologies Australia; operated via PPE Whispr Division Pty Ltd (incorporated 26 May 2025) | Residential households (CHBP) | FY25 launch; early traction FY26 | — |
| Escape Series BESS (incl. Escape 215) | Easy-to-install BESS adapted to Australian climates; Escape 215 is a larger (215 kWh-class) C&I system | Farms, eco-tourism, mines, commercial | Escape series in FY24; Escape 215 in FY26 | — |
| Containerised stand-alone power systems | Containerised SAPS for remote and mining applications (e.g. a WA mine-site wireless mesh network) | Mining, remote infrastructure | FY24 projects | Project-based |
| Installer training (CPD) | Accredited installer training awarding Continuing Professional Development points | Installers | FY24 | — |
Notable installations (FY24 Annual Report): Louth Island (SA, eco-tourism); a major WA mine site; the McNeil Dairy Project for Willows Pastoral (Vic). PPE attained ISO 9001 certification in FY24.
Manufacturing capacity project: a A$6.7m project, supported by a A$2.3m ARENA Battery Breakthrough Initiative grant (April 2026), to expand and semi-automate module manufacturing in Melbourne. The target is up to 150 MWh of modules per year, roughly a three-fold increase over two years (FY26 Annual Report).
Advanced Batteries — Li-S Energy (associate, 39.11%; ASX-listed)
| Product / capability | Description | Target customer | Status |
|---|---|---|---|
| Lithium-sulfur pouch cells (10Ah commercial format) | 456 Wh/kg post-formation energy density on a commercial-sized 10Ah Li-S cell (FY25) | Drones, defence, electric aviation | Prototype/sample deliveries; first US Government delivery August 2026 |
| Power Cell architecture | 2C continuous discharge on a commercial 10Ah cell — about 10 times the power of a typical high-energy-density Li-S cell (FY26) | Drone, defence, mission-critical | Development/validation |
| Lithium-metal cells | Lithium-metal anodes protected by Li-nanomesh to reduce dendrites | Aviation, defence | Development |
| Small-format cells (Phase 3S line) | Smaller-format cell line in the dry room | Smaller devices | Commissioned FY25 |
| Battery packs and proprietary BMS | First packs delivered to V-TOL Aerospace under the EATP grant; BMS tailored to Li-S chemistry | Drone OEMs | First deliveries FY26 |
| Lithium metal foil | Described as Australia's first dedicated lithium-metal-foil production capability (Geelong); ISO 9001:2015 certified; first commercial sale FY26 | Battery manufacturers / researchers | Early commercial |
| Phase 3 facility | A$10m facility; described as Australia's largest pouch-cell manufacturing facility; Battery Test Centre (drop, crush, nail penetration, altitude, thermal) | Internal | Opened 9 August 2024 |
| Phase 4 scale-up study | A$7.8m ARENA Advancing Renewables Program grant for a feasibility study toward up to 1 GWh per year; Hatch appointed for FEL-1 | — | Feasibility (first A$1.9m tranche received March 2026 quarter) |
Regulatory milestones: AUKUS accreditation for dual-use Li-S cell exports to the US and UK without permits (FY25); approvals to airfreight prototype cells internationally (FY26). LIS also held an investment in US-based Zeta Energy (FY22 Annual Report, which notes foreign-exchange movements on that investment).
Nanomaterials — White Graphene Ltd / BNNT Technology (associate, 39.36%)
| Product | Description | Target customer | Status |
|---|---|---|---|
| White graphene (boron nitride nanosheets, BNNS) | 2D boron nitride; FY22 Annual Report describes it as 138 times stronger than steel, four times lighter, three times more thermally conductive than copper, corrosion resistant, hydrogen-impermeable, radiation-shielding. Production exceeds 20 kg per day after optimisation (FY25) | Coatings, lubricants, composites, paints, luxury watch composites, LIS battery chemistries | Evaluation and validation stage; no material revenue forecast for FY26 |
| Boron nitride nanotubes (BNNT) | Nanoscale reinforcement; FY22 targeted capacity of about 500 kg per year at more than 95% purity; company believes it is the lowest-cost BNNT producer globally | Research buyers (typically orders under 10 g), LIS, space agency samples | Production capability reduced; limited market demand |
| BNNT-X | BNNT derivative, lab-scale process at Deakin Geelong | Partners | Not progressed beyond lab scale (FY25) |
| Regulatory | AICIS approval under the Industrial Chemicals Act 2019 covering white graphene and BNNT; independent toxicity tests found no acute toxicity concerns | — | Approved FY25 |
Discontinued, divested or halted lines (for completeness)
| Line | Description | Outcome |
|---|---|---|
| Craig International Ballistics | Body armour; opaque and transparent armour for vehicles, aircraft and vessels; Hunter Class Frigate transparent armour and wiper systems; a A$30m ADF body-armour order (FY24); the southern hemisphere's largest ballistic-industry hydraulic press (FY25) | Sold 29 June 2026 to Mehler (Germany) |
| AMAG (Advanced Mobility Analytics Group) | AI road-safety SaaS (SMART Survey, Operations, Safety) | Sold October 2024 to Transoft Solutions |
| Precious Metals (BNNT in gold/silver/copper) | Metal matrix composites (45% interest) | Gold research did not show the expected benefits (FY25) |
| Strategic Alloys | JV with Amaero International (ASX: 3DA) for BNNT in aluminium and titanium alloys (45%) | No commercial outcome disclosed |
| 3D Dental Technology | BNNT in zirconia and lithium disilicate dental ceramics (45%) | Halted FY22; A$0.356m written off |
| Ballistic Glass | BNNT in bullet-resistant glass and body-armour ceramics (40%) | Not progressed (FY22 review) |
| Survivon / Mask Innovations | Copper-coated antiviral masks | Survivon exited August 2022; Mask Innovations' later status not disclosed |
| PPK Mining Equipment | Mining equipment manufacturing | Demerged June 2022 |
| Plaspak packaging | Plastic packaging | Legacy business |
Financial Narrative
Basis of preparation note. PPK has re-presented comparatives almost every year because of discontinued operations (mining FY22; LIS FY25; WGL FY26). Each year column below uses the latest available presentation of that year:
-
FY22: FY22 Annual Report (continuing operations; excludes A$37.871m of mining revenue).
-
FY23: FY24 Annual Report.
-
FY24: FY25 Annual Report (re-presented for the LIS deconsolidation).
-
FY25: FY26 Annual Report (re-presented for the WGL deconsolidation).
-
FY26: FY26 Annual Report.
All figures are A$k unless noted.
Income statement
EBITDA and operating income. PPK does not report group EBITDA or an operating income subtotal; both are not publicly disclosed. The only disclosed EBITDA is PPE's FY26 EBITDA of A$1.3m (non-IFRS).
Margins and growth
The calculations are derived from the table above.
-
Revenue CAGR FY23–FY26 (three years) is about 65.3%, distorted by PPE joining in May 2023.
-
Revenue CAGR FY24–FY26 (two years, the first full-year PPE base) is about 0.9%.
-
FY23 gross margin covers only two months of PPE plus minor revenue and is not comparable.
Commentary. Statutory results are dominated by non-operating items, and should be read through the underlying line:
FY22: an A$11.6m BNNT remeasurement gain.
FY25: an A$22.4m LIS impairment, an A$3.2m AMAG impairment and an A$12.2m LIS deconsolidation gain.
FY26: an A$18.3m CIB gain, an A$6.9m WGL deconsolidation gain and an A$6.9m LIS impairment reversal.
On the underlying line the trajectory is unambiguously improving: losses narrowed from A$(15.9)m in FY24 to A$(9.5)m in FY25 and A$(4.0)m in FY26. The drivers are deconsolidation of cash-burning R&D entities, PPE's turnaround to small profitability, and a A$1.7m reduction in corporate underlying cost over two years.
The FY26 statutory profit of A$19.2m is non-recurring. Excluding the CIB gain (after tax A$13.7m), the WGL gain (after tax A$6.2m) and the LIS reversal (after tax A$5.1m), the attributable result would be a loss of roughly A$5.9m. This is an arithmetic illustration only, not a company-disclosed figure.
FY27 will lose the CIB equity-accounted contribution (A$2.8m underlying in FY26, A$4.7m in FY25). That removes the group's only consistently profitable asset from the earnings base.
Balance sheet
Sources: FY22, FY24, FY25 and FY26 Annual Reports. FY23 parent cash is from the FY24 Annual Report. FY22 NTA per share is "from continuing operations". NTA methodology changed in FY25/FY26 to also exclude intangibles and deferred tax. The adjusted (non-IFRS) NTA, which adds back the LIS impairment, was 59.3c in FY25 and 64.7c in FY26.
Commentary. The FY22–FY24 balance sheet was flattered by cash sitting inside LIS from its A$34m IPO — only A$4–5m was held by the parent. Deconsolidation in October 2024 removed A$19.3m of LIS cash and about A$39m of intangibles. By 30 June 2025 the group had net current liabilities of A$2.6m and only A$3.6m of parent cash, and the FY25 accounts carried an explicit going-concern discussion. The CIB sale transformed this: parent cash rose to A$25.7m, working capital returned to A$19.4m, and borrowings fell after a A$2.0m loan secured over part of the CIB stake was repaid.
Remaining debt. Residual borrowings of about A$3.8m are mainly PPE-level:
-
external convertible notes at 10% interest, maturing August 2027, of which A$0.8m is held by Glenn Molloy-related entities; and
-
a loan from PPE minority shareholder Altus Construction, extended to 31 August 2026.
The status of the Altus loan after that date is not disclosed in the materials reviewed.
Off-balance-sheet value. Not recognised:
-
the CIB earn-out of up to about A$6.0m, to be determined in H1 FY28;
-
the AMAG uncapped earn-out; and
-
any premium for strategic control of the LIS block.
Cash flow
Notes:
-
The FY26 cash flow statement was only partially captured in the source excerpt reviewed: receipts from customers were A$33.170m and payments to suppliers and employees A$(37.242)m.
-
CIB sale proceeds of A$27.2m were received on 30 June 2026 and fall in investing activities.
-
Employee share trust purchases of 120,507 shares at A$0.33 in May 2026 are not material.
-
FY22 in-specie figure is the PPKMEG demerger dividend; the 15.11c capital return totalled A$13.49m.
-
The FY24 buy-back was a minimum holding buy-back.
Commentary. PPK has generated negative operating and free cash flow in every year from FY22 to FY25, cumulatively about A$60m of FCF burn over four years. That burn was funded by subsidiary capital raisings (LIS IPO, WGL raises), asset sales and government grants. FY26's cash generation came almost entirely from realising CIB (A$27.2m) and CIB distributions (A$2.4m). Over its holding period, CIB returned A$9.4m in distributions plus A$27.7m (A$27.2m cash and A$0.5m deferred) in sale proceeds, against the A$5.0m invested in December 2019 — a 642% total return per the company.
Ratios
Notes:
- All ratios are dossier calculations from reported figures. FY22 averages use FY21 closing balances (total assets A$96.602m; attributable equity A$76.648m).
ROIC: not meaningful, because operating income is not disclosed and earnings are dominated by non-operating gains.
Net debt/EBITDA: not meaningful, because group EBITDA is not disclosed and PPK is in net cash in four of five years.
Cash conversion cycle: not reliably computable, because trade payables are not separated from other payables in the excerpts reviewed. An indicative FY26 calculation (inventory 113 days + receivables about 47 days − payables about 201 days) gives a negative cycle, but the payables figure includes non-trade items. This should be treated as indicative only.
FY26 ROE and ROA: reflect one-off gains and are not representative of recurring returns.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | PPK interest | Accounting | Activity | Status |
|---|---|---|---|---|
PowerPlus Energy Pty Ltd (incl. PPE Whispr Division Pty Ltd) | 75.40% | Controlled subsidiary | LFP battery and BESS manufacturing (Melbourne) | Operating |
Li-S Energy Limited (ASX: LIS) | 39.11% (about 251m shares) | Associate (equity method) | Lithium-sulfur and lithium-metal cells; lithium foil | Pre-commercial / early revenue |
White Graphene Limited (incl. BNNT Technology Pty Ltd) | 39.36% | Associate (equity method) | Boron nitride nanosheets and nanotubes | Pre-revenue |
PPK Investment Holdings Pty Ltd | 100% | Subsidiary | Holds PPE convertible notes | — |
BNNT Ballistics Pty Ltd | 100% | Subsidiary | Former holder of the CIB stake | CIB sold 29 Jun 2026 |
PPK Plans 2 Pty Ltd | Trustee | Employee share trust | LTI administration | — |
Craig International Ballistics Pty Ltd | 0% (was 39.85%) | Associate until 29 Jun 2026 | Ballistic protection | Divested |
AMAG Holdings Australia Pty Ltd | 0% (was 30%) | Associate until 16 Oct 2024 | AI road-safety SaaS | Divested; earn-out |
Segment revenue (AUD K)
| Segment revenue (AUD K) | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
PowerPlus Energy sales revenue (AUD K) | 5,081 | 27,471 | 22,990 | 27,764 |
Consolidated revenue from contracts with customers (AUD K) | 6,352 | 28,186 | 24,092 | 28,709 |
CIB revenue, 100% basis, not consolidated (AUD K) | — | — | 48,100 | — |
Results by Segment
| Underlying PBT by segment (AUD K) | FY24 | FY25 | FY26 |
|---|---|---|---|
PPE Energy Storage underlying PBT (AUD K) | -2,451 | -2,769 | 424 |
WGL and BNNT nanomaterials underlying PBT incl. associate share (AUD K) | -4,153 | -2,532 | -1,696 |
LIS Energy underlying PBT incl. associate share (AUD K) | -3,919 | -3,465 | -1,900 |
CIB associate share of profit (AUD K) | 1,844 | 4,718 | 2,799 |
AMAG associate share (AUD K) | -719 | -193 | 0 |
Corporate underlying cost (AUD K) | -6,483 | -5,303 | -3,580 |
Total underlying PBT (AUD K) | -15,881 | -9,544 | -3,953 |
FY26 Item Details
| FY26 item (AUD K) | PPE | WGL/BNNT disc. | WGL/BNNT assoc. | LIS | CIB | Corporate | Total |
|---|---|---|---|---|---|---|---|
Reported PBT | 35 | 5,929 | -688 | 4,959 | 21,107 | -3,833 | 27,509 |
Gain on deconsolidation | 0 | -6,937 | 0 | 0 | 0 | 0 | -6,937 |
Gain on disposal of CIB | 0 | 0 | 0 | 0 | -18,308 | 0 | -18,308 |
Amortisation of acquired intangibles | 389 | 0 | 0 | 0 | 0 | 0 | 389 |
Impairment reversal (LIS) | 0 | 0 | 0 | -6,859 | 0 | 0 | -6,859 |
Legal provision reversal | 0 | 0 | 0 | 0 | 0 | 253 | 253 |
Underlying PBT | 424 | -1,008 | -688 | -1,900 | 2,799 | -3,580 | -3,953 |
Income statement (AUD K)
| Income statement (AUD K) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Revenue from contracts with customers (AUD K) | 1,647 | 6,352 | 28,186 | 24,092 | 28,709 |
Cost of sales (AUD K) | — | -3,446 | -20,165 | -17,144 | -19,717 |
Gross profit (AUD K) | — | 2,906 | 8,021 | 6,948 | 8,992 |
Share of associates profit/(loss) (AUD K) | -4,039 | 135 | 1,125 | 2,781 | 211 |
Finance costs (AUD K) | — | -382 | -1,565 | -1,081 | -1,185 |
Profit/(loss) before tax, continuing ops (AUD K) | -7,024 | -12,643 | -13,326 | -30,823 | 21,580 |
Income tax benefit/(expense), continuing (AUD K) | 503 | 770 | 1,354 | 3,696 | -7,555 |
Profit/(loss) after tax, continuing ops (AUD K) | -6,521 | -11,873 | -11,972 | -27,127 | 14,025 |
Profit/(loss) after tax, discontinued ops (AUD K) | -649 | 0 | -3,919 | 1,410 | 5,226 |
Net profit/(loss) after tax, total (AUD K) | -7,170 | -11,873 | -15,891 | -25,717 | 19,251 |
Net profit/(loss) attributable to owners of PPK (AUD K) | -2,564 | -7,815 | -10,743 | -21,553 | 19,213 |
Underlying PBT, non-IFRS (AUD K) | — | — | -15,881 | -9,544 | -3,953 |
Basic EPS (A$ cents) | -2.9 | -8.8 | -12.1 | -23.8 | 21.2 |
Diluted EPS (A$ cents) | -2.9 | -8.8 | -12.1 | -23.8 | 20.4 |
Dividends per share, incl. in-specie (A$ cents) | 2.81 | 0 | 0 | 5.71 | 0 |
Capital return per share (A$ cents) | 15.11 | 0 | 0 | 0 | 0 |
Margins and growth (%)
| Margins and growth (%) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Gross margin (%) | — | 45.7 | 28.5 | 28.8 | 31.3 |
PBT margin, continuing (%) | -426.5 | -199.0 | -47.3 | -127.9 | 75.2 |
Net margin, total NPAT / revenue (%) | -435.3 | -186.9 | -56.4 | -106.7 | 67.1 |
Underlying PBT margin (%) | — | — | -56.3 | -39.6 | -13.8 |
Revenue growth YoY (%) | — | 285.7 | 343.7 | -14.5 | 19.2 |
Balance Sheet and Per-Share Data
| Balance sheet (AUD K) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Total assets (AUD K) | 120,976 | 135,580 | 122,846 | 73,604 | 91,269 |
Cash and cash equivalents (AUD K) | 53,008 | 39,999 | 28,348 | 5,058 | 27,674 |
Cash held directly by PPK parent (AUD K) | 4,810 | 3,840 | 4,456 | 3,565 | 25,679 |
Borrowings, current (AUD K) | 0 | 0 | 2,834 | 5,206 | 3,248 |
Borrowings, non-current (AUD K) | 2,756 | 3,346 | 604 | 555 | 591 |
Total borrowings excl. leases (AUD K) | 2,756 | 3,346 | 3,438 | 5,761 | 3,839 |
Lease liabilities, total (AUD K) | 1,300 | 6,327 | 6,972 | 4,124 | 3,131 |
Net debt excl. leases, negative = net cash (AUD K) | -50,252 | -36,653 | -24,910 | 703 | -23,835 |
Investments accounted for using equity method (AUD K) | 10,762 | 9,814 | 9,236 | 34,955 | 38,731 |
Intangible assets and goodwill (AUD K) | 37,475 | 44,617 | 44,770 | 5,657 | 3,708 |
Inventories (AUD K) | 313 | 12,077 | 7,518 | 7,485 | 6,129 |
Total current assets (AUD K) | 55,658 | 57,927 | 42,555 | 21,590 | 39,180 |
Total current liabilities (AUD K) | 3,397 | 18,057 | 21,831 | 24,195 | 19,802 |
Working capital (AUD K) | 52,261 | 39,870 | 20,724 | -2,605 | 19,378 |
Total liabilities (AUD K) | 8,391 | 29,870 | 28,927 | 28,514 | 29,417 |
Equity attributable to owners of PPK (AUD K) | 81,510 | 75,581 | 67,743 | 41,932 | 61,893 |
Non-controlling interests (AUD K) | 31,075 | 30,129 | 26,176 | 3,158 | -41 |
Total equity (AUD K) | 112,585 | 105,710 | 93,919 | 45,090 | 61,852 |
Net tangible assets per share, statutory (A$ cents) | 81.83 | 58.29 | 43.79 | 40.7 | 70.3 |
Cash flow (AUD K)
| Cash flow (AUD K) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Net cash from operating activities (AUD K) | -8,070 | -9,549 | -9,910 | -6,903 | — |
Payments for property, plant and equipment (AUD K) | -2,929 | -3,468 | -6,202 | -1,581 | — |
Payments for intangibles, capitalised development (AUD K) | -4,774 | -3,664 | -2,377 | -912 | — |
Free cash flow, OCF minus PP&E and intangibles (AUD K) | -15,773 | -16,681 | -18,489 | -9,396 | — |
Cash dividends paid by PPK (AUD K) | 0 | 0 | 0 | 0 | 0 |
In-specie dividends, non-cash (AUD K) | 2,509 | 0 | 0 | 5,189 | 0 |
Share buy-backs (AUD K) | 0 | 0 | 278 | 0 | 0 |
Proceeds from government grants for capital acquisitions (AUD K) | — | 0 | 3,592 | 868 | — |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
ROE on avg attributable equity (%) | -3.2 | -9.9 | -15.0 | -39.3 | 37.0 |
ROA on avg total assets (%) | -6.6 | -9.3 | -12.3 | -26.2 | 23.4 |
Current ratio (x) | 16.38 | 3.21 | 1.95 | 0.89 | 1.98 |
Debt to total equity, excl. leases (x) | 0.024 | 0.032 | 0.037 | 0.128 | 0.062 |
Asset turnover, revenue / avg total assets (x) | 0.015 | 0.050 | 0.218 | 0.245 | 0.348 |
Interest coverage, (PBT + finance cost) / finance cost (x) | — | -32.1 | -7.5 | -27.5 | 19.2 |
Inventory days on cost of sales (days) | — | — | — | 159 | 113 |
Geographic revenue (AUD K)
| Geographic revenue (AUD K) | FY24 | FY25 | FY26 |
|---|---|---|---|
Australia, consolidated revenue, company indicates domestic operations (AUD K) | 28,186 | 24,092 | 28,709 |
Segment Overview
| Segment | Australia | International |
|---|---|---|
PPE (consolidated) | All disclosed sales channels are Australian | None disclosed |
LIS (associate, not consolidated) | Geelong manufacturing; Australian grant funding | US defence engagement (Paladin Defense Services as US representative; DEVCOM C5ISR delivery August 2026); UK (MSubs); New Zealand (Kea Aerospace) |
WGL/BNNT (associate) | Geelong production | International distributors appointed FY26; samples to an international space agency and a European watchmaker |
CIB (divested) | Gold Coast manufacturing; ADF customer | International interest cited; now owned by a German acquirer |
Share price and TSR
| Share price and TSR | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|
Share price at 30 June (AUD) | 0.30 | 2.77 | 3.11 | 15.95 | 2.04 | 1.38 | 0.38 | 0.325 | 0.35 |
Annual shareholder return as reported (%) | 50 | 823 | 13 | 414 | -86 | -32 | -72 | 1 | 8 |
Period Price Performance to 30 June 2026 Details
| Period price performance to 30 June 2026 | Value |
|---|---|
1-year (FY26) price change | +7.7% (A$0.325 to A$0.35); company-reported shareholder return 8% |
3-year (FY23 end to FY26 end) | −74.6% (A$1.38 to A$0.35) |
5-year (FY21 end to FY26 end) | −97.8% (A$15.95 to A$0.35) |
52-week range (to July 2026) | A$0.29 – A$0.72 (StockAnalysis) |
Recent trading | A$0.345 (17 July 2026); A$0.35–0.36 around the 6 August 2026 buy-back notice (InvestSMART). |
Valuation Snapshot
| Multiple | Value | Comment |
|---|---|---|
Market capitalisation | about A$31.7m | 0.35 × 90.56m. Aggregators: A$31.2m (StockAnalysis, July 2026); A$36.7m (Simply Wall St, September 2026) |
P/E (statutory FY26) | about 1.7x | Distorted by one-off gains; not meaningful |
P/B (attributable equity A$61.9m) | about 0.51x | Book value per share about 68c |
P/NTA (70.3c) | about 0.50x | Company view: material discount to underlying value |
Enterprise value (dossier calculation) | about A$11.0m | Market cap A$31.7m + borrowings A$3.8m + leases A$3.1m − cash A$27.7m. Discrepancy: Eulerpool shows EV of A$40.52m (6 August 2026), apparently not netting the post-sale cash |
EV/Sales | about 0.38x | On FY26 revenue of A$28.7m |
Sum-of-parts reference points | Parent cash about A$25.7m (28.4c per share) + LIS stake at 12.5c × 251m ≈ A$31.4m (34.6c per share) | Before PPE, WGL, earn-outs, corporate costs and tax; illustrative only |
Dividend history
| Dividend history | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
Dividends per share (A$ cents) | 2.0 | 3.5 | 2.81 | 0 | 0 | 5.71 | 0 |
Analyst Conclusions
Management guidance
There is no quantitative guidance. Qualitatively, the Board:
-
expects to conclude a cornerstone acquisition within FY27;
-
will update shareholders at the 24 November 2026 AGM;
-
will run the buy-back of up to A$2.5m;
-
will keep supporting PPE's scale-up and associates; and
-
considers FY27 the start of its strongest strategic position to date (FY26 Chair's Report).
Consensus
There is no sell-side consensus (zero coverage).
Bull case
-
Deep discount to tangible value. At about A$0.35 the shares trade at about 0.5x statutory NTA (70.3c). Parent cash alone is about 28c per share, and the LIS block at 30 June marks is about 35c per share. That implies negative value for PPE, WGL, the CIB earn-out (up to A$6.0m) and the AMAG earn-out.
-
Capital-allocation credibility. The CIB exit (642% total return) shows the Board can buy, nurture and sell well. A disciplined cornerstone acquisition funded from about A$25m of cash, without dilution, could convert PPK from a discount-laden holding company into an earnings-based investment case.
-
Operating and associate momentum. PPE has turned EBITDA-positive (A$1.3m), with ARENA-backed capacity tripling to 150 MWh. LIS's first US Army DEVCOM delivery and its A$7.8m ARENA scale-up grant create optionality on a 251m-share stake.
Bear case
-
Earnings vacuum. With CIB gone, the underlying business is a near-breakeven PPE plus A$3.6m of corporate cost and equity-accounted losses from LIS and WGL. The underlying FY26 loss of A$4.0m included A$2.8m of CIB profit that will not recur.
-
Execution and governance risk. A three-director board with no CEO is searching for a transformational acquisition in a competitive M&A market. The history of failed incubations (3D Dental, Precious Metals, Survivon, BNNT demand) argues for caution about capital deployment.
-
Structural pressure on PPE and volatile associates. Import competition and CHBP-driven pricing compress margins. LIS valuation swings (an A$22.4m impairment followed by partial reversal) can repeatedly hit reported equity, and associates may need more capital.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | What to watch |
|---|---|---|
| 2026 AGM acquisition update | 24 Nov 2026 | Target sector, size, valuation discipline, funding mix |
| Buy-back execution | FY27 | Shares cancelled; average price versus NTA |
| H1 FY27 results | Late Feb 2027 | PPE revenue and EBITDA run-rate; corporate cost; cash burn after CIB |
| PPE financing | Ongoing (Altus loan maturity 31 Aug 2026; notes Aug 2027) | Refinancing or conversion; PPK support |
| PPE ARENA project | FY27 | Supplier contracts; commissioning; unit cost |
| CHBP program settings | Ongoing | Rebate changes affecting residential pricing |
| LIS milestones | Ongoing | DEVCOM evaluation results; US orders; Phase 4 FEL-1 outcome; LIS share price (drives PPK impairment testing) |
| WGL commercial outcomes | Ongoing | Any first supply agreement |
| CIB earn-out | H1 FY28 | Milestone achievement (up to about A$6.0m) |
| Board / CEO appointments | FY27 | Board depth; leadership arriving with an acquisition |
Analyst verdict
PPK Group enters FY27 as a fundamentally different company from the one that peaked at A$15.95 a share in 2021. The technology-incubator thesis has largely been unwound. LIS and the nanomaterials business are deconsolidated minority stakes, the speculative application projects have been written off, and the group's best asset, Craig International Ballistics, has been sold for a 642% total return. What remains is A$27.7m of cash, a sub-scale but improving Australian battery manufacturer, a 39% block in a listed lithium-sulfur developer, a 39% stake in a pre-revenue nanomaterials company, and contingent earn-outs.
On paper the stock is cheap. It trades at roughly half of statutory NTA, and parent cash plus the LIS stake at 30 June marks exceed the market capitalisation. The Board's insider buying in April 2026 and its preference for a buy-back over a dividend signal that it shares that view.
The discount is not irrational, however. PPK has burned free cash flow in every disclosed year before FY26, its recurring earnings base is now negative without CIB, and its future depends on a single large decision — the cornerstone acquisition — to be taken by a three-person board without a chief executive. The company's history includes both outstanding (CIB) and poor (Survivon, BNNT applications, AMAG) capital-allocation outcomes, so the market is reasonably reserving judgement.
The investment case is therefore event-driven rather than earnings-driven. If the AGM update shows a disciplined, cash-generative Australian acquisition at a sensible multiple, the NTA discount should narrow materially. A dilutive, expensive or off-strategy deal would likely entrench it, as would continued drift. Absent sell-side coverage, the decisive monitorables are:
-
the November 2026 AGM disclosure;
-
PPE's H1 FY27 EBITDA run-rate;
-
PPE's refinancing; and
-
LIS's US defence validation results.
On balance the asset backing offers a margin of safety, but realising value requires execution the company has yet to demonstrate in its new form.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed / tenure | Background and education | Age | PPK shares held |
|---|---|---|---|---|---|
Anne-Marie Birkill | Independent Non-Executive Chair; Chair of Nomination & Remuneration Committee; member of Audit & Risk Committee | Director since 1 July 2022; Chair since 1 July 2024 | BSc (Hons), MBA, GAICD. Founding Partner and director of OneVentures (VC); NED of UniQuest (University of Queensland commercialisation company) and InterFinancial Corporate Finance; chairs the investment committee of the A$150m UQ-led Food and Beverage Accelerator; former CEO of i.lab incubator and GM of UniQuest | 58 in 2022 (FY22 Annual Report); about 62 now | 27,400 |
Glenn Molloy | Executive Director; member of Nomination & Remuneration Committee | Founder 1979; on the Board since listing (1994); Executive Director since September 2009 | Founder of Plaspak; M&A and divestment adviser; director of PPE (and CIB until the sale) | 67 in 2022; about 71 now | 22,237,457 (about 24.6% of shares on issue) |
Rick (Richard) Francis | Independent Non-Executive Director; Chair of Audit & Risk Committee; member of Nomination & Remuneration Committee | Since 2 December 2024 | BCom, MBA, GAICD, CA. Former MD/CEO and earlier CFO of Spark Infrastructure (ASX 100); former NED of Victoria Power Networks and SA Power Networks; Deputy Chair of TransGrid; senior roles at APA and Origin Energy; NED of Li-S Energy (since 18 February 2025) | — | 155,000 (bought in April 2026) |
“—” = not publicly disclosed.
Executive Leadership Team
| Name | Title | Since | Prior roles / education |
|---|---|---|---|
Sarah Price | Chief Financial Officer (KMP) | Joined 28 March 2022; CFO from 23 May 2023 | Not detailed in the reports reviewed |
Will Shiel | General Counsel and Company Secretary | 16 August 2021 | BA (Hons) Law, FGIA; former Head of Legal (Technology) at ASX Limited; Allens Linklaters, Gilbert+Tobin, Clifford Chance |
Liam Fairhall | Deputy General Counsel and Company Secretary | 30 June 2022 | BLaw (Hons), BMed Rad Sci, Grad Dip ACGRM; former Head of Legal/CoSec at a payments-focused bank |
Group CEO | Vacant | Since 5 December 2025 | The Board says a standalone CEO is not currently required and that an acquired business may bring a future Group leader (FY26 Chair's Report) |
Directors' Remuneration
| KMP | Cash salary and fees | Cash bonus | Superannuation | Share-based | Total FY26 | Total FY25 |
|---|---|---|---|---|---|---|
Anne-Marie Birkill (Chair) | 100,000 | 0 | 0 | 0 | 100,000 | 100,000 |
Rick Francis (NED) | 170,089 | 0 | 20,411 | 0 | 190,500 | 42,500 |
Glenn Molloy (Exec. Director) | 227,500 | 0 | 0 | 0 | 227,500 | 212,500 |
Marc Fenton (MD/CEO, to 5 Dec 2025) | 217,218 | 97,520 | 15,000 | 0 | 329,738 | 653,058 |
Sarah Price (CFO) | 300,001 | 86,670 | 30,000 | 156,418 | 573,089 | 534,957 |
Total KMP | 1,014,808 | 184,190 | 65,411 | 156,418 | 1,420,827 | 1,566,348 |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
1 Jul 2024 | Birkill becomes Chair; Fenton becomes MD | Board restructure after Levison's announced retirement |
31 Aug 2024 | Levison retires | Chair since 2013 (executive and non-executive periods) |
2 Dec 2024 | Francis appointed | Outcome of an external search for energy-sector experience |
6 Jun 2025 | Fenton resigns (six-month notice) | Rights assessed as good leaver; partial forfeiture |
5 Dec 2025 | Fenton departs; CEO role not replaced | Board considers a standalone CEO unnecessary at current scale |
Major Shareholders
| Holder | Shares | Approx. % of ~90.56m | Source |
|---|---|---|---|
Glenn Molloy and related parties | 22,237,457 | 24.6 | FY26 Annual Report |
Sarah Price (CFO) | 378,996 | 0.4 | FY26 Annual Report |
Rick Francis | 155,000 | 0.2 | FY26 Annual Report |
Anne-Marie Birkill | 27,400 | 0.03 | FY26 Annual Report |
Employee share trusts | 90,000 (FY26 report); 468,344 (FY25 report date) | 0.1–0.5 | Annual Reports |
Total KMP holdings | 22,798,853 | about 25.2 | FY26 Annual Report |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Type | Relative positioning vs PPK portfolio |
|---|---|---|---|
Stationary storage (PPE) | Tesla (Powerwall) | Global OEM | Dominant residential brand; far larger scale and lower cost |
Stationary storage (PPE) | BYD (Battery-Box) | Global cell and system maker | Vertically integrated cells; strong in rack-mount LFP |
Stationary storage (PPE) | Sungrow | Global inverter and ESS | Integrated inverter and battery |
Stationary storage (PPE) | Alpha ESS | Chinese ESS supplier | Aggressive pricing in the Australian residential market |
Stationary storage (PPE) | SolaX Power | Chinese inverter and battery | Price competitor |
Stationary storage (PPE) | Redback Technologies | Australian (Brisbane) hybrid inverter/battery | Local brand competitor (not to be confused with Redx, a PPE partner) |
Stationary storage (PPE) | Zenaji | Australian LFP/LTO battery brand | Direct "Australian" positioning competitor |
Stationary storage (PPE) | Energy Renaissance | Australian cell and battery manufacturer (NSW) | Sovereign-manufacturing peer |
Stationary storage (PPE) | Enphase (IQ Battery) | Global microinverter and battery | Premium residential |
Lithium-sulfur (LIS) | Lyten (US) | Li-S developer | Larger funded US competitor |
Lithium-sulfur (LIS) | Zeta Energy (US) | Li-S developer (LIS has held an investment) | Peer and partner |
Lithium-sulfur (LIS) | Theion (Germany) | Li-S developer | European peer |
Lithium-sulfur (LIS) | Gelion (ASX: GN1) | Li-S and zinc battery developer | ASX-listed peer |
BNNT (WGL) | BNNT LLC (US); Tekna (Canada); BNNano (US) | BNNT producers | Peers in a nascent market with no material volume sales globally (company view) |
Ballistics (former CIB) | Point Blank, Ceradyne, other armour makers | Global armour suppliers | No longer relevant after the sale |
Competitor Detail
| Metric | PPK Group (consolidated) |
|---|---|
Revenue | A$28.7m (FY26) |
Revenue growth | +19.2% (FY26) |
Gross margin | 31.3% (FY26) |
R&D intensity | Not disclosed (proxy nil consolidated in FY26) |
Recent Developments
Headcount reductions occurred implicitly through the deconsolidations.



